Side-Chain Derivatives of Biologically Active Nucleosides. Part 2: Synthesis and anti-HIV Activity of 5′-C-Methyl Derivatives of 3′-Fluoro-3′-Deoxythymidine
Free accessBrief reportFirst published online June, 1996
Side-Chain Derivatives of Biologically Active Nucleosides. Part 2: Synthesis and anti-HIV Activity of 5′-C-Methyl Derivatives of 3′-Fluoro-3′-Deoxythymidine
1-(3′-Fluoro-2′,3′,6′-trideoxy-β-D-allofuranosyl)thymine [7] and 1-(3′-fluoro-2′,3′,6′-trideoxy-α-L-talofuranosyl) thymine [8] were synthesized starting from the corresponding 2,3′-anhydro nucleoside derivatives. The fluorine was introduced stereoselectively by opening of the anhydro bridge in the presence of HF/AIF3. The 5′-C-methyl derivatives, [7] and [8], of 3′-fluoro-3′-deoxythymidine (FLT) were evaluated for their inhibitory effect against human immunodeficiency virus type 1 (HIV-1) and type 2 (HIV-2). The compounds [7] and [8] had antiviral activity which was three orders of magnitude lower than the reference compound 3′-fluoro-3′-deoxythymidine. None of the compounds showed appreciable activity against other RNA or DNA viruses at subtoxic concentrations.
BalzariniJ.BabaM.PauwelsR.HerdewijnP., and De ClercqE. (1988) Anti-retrovirus activity of 3′-fluoro- and 3′-azido substituted pyrimidine 2′,3′-dideoxynucleoside analogues. Biochem Pharmacol37: 2847–2856.
2.
BalzariniJ.BohmanC., and De ClercqE. (1993) Differential mechanism of cytostatic effect of (E)-5-(2-bromovinyl)-2′-deoxyuridine, 9-(1,3-dihydroxy-2-propoxymethyl)-guanine, and other antiherpetic drugs on tumor cells by the thymidine kinase gene of herpes simplex virus type 1 or type 2. J Biol Chem268: 6332–6337.
3.
BalzariniJ.KarlssonA.MeichsnerC.PaessensC.RiessG.De ClercqE., and KleimJ.-P. (1994) Resistance pattern of human immunodeficiency virus type 1 reverse transcriptase to quinoxaline S-2720. J Virol68: 7986–7992.
4.
BergstromD.E.MottA.W.De ClercqE.BalzariniJ., and SwartlingD.J. (1992) 3′, 3′-Difluoro-3′-deoxythymidine: Comparison of anti-HIV activity to 3′-fluoro-3′-deoxythymidine. J Med Chem35: 3369–3372.
5.
ChengY.-C.DutschmanG.E.BastowK.F.SamgadharanM.G., and TingR.Y.C. (1987) Human immunodeficiency virus reverse transcriptase. General properties and its interactions with nucleoside triphosphate analogs. J Biol Chem262: 2187–2189.
6.
De ClercqE. (1992) HIV inhibitors targeted at the reverse transcriptase. AIDS Res Hum Retroviruses8: 119–134.
7.
De ClercqE. (1995a) Toward improved anti-HIV chemotherapy: Therapeutic strategies for intervention with HIV infections. J Med Chem38: 2491–2517.
8.
De ClercqE. (1995b) Trends in the development of new antiviral agents for the chemotherapy of infections caused by herpesviruses and retroviruses. Rev Med Virol5: 149–164.
9.
De ClercqE.van AerschotA.HerdewijnP.BabaM.PauwelsR., and BalzariniJ. (1989) Anti-HIV activity of 2′, 3′-dideoxynucleoside analogues: Structure-activity relationship. Nucleosides & Nucleotides8: 659–671.
10.
Génu-DellacC.GosselinG., and ImbachJ.-L. (1991) Synthesis of new 2′-deoxy-3′-substituted - α -L-threo-pentofuranonucleosides of thymine as potential antiviral agents. Tetrahedron Lett32: 79–82.
11.
HieblJ.ZbiralE.BalzariniJ., and De ClercqE. (1992) Side-chain derivatives of biologically active nucleosides. 1. Side-chain analogs of 3′-azido-3′-deoxythymidine (AZT). J Med Chem35: 3016–3023.
12.
HighcockR.M.HilpertH.MyersP.L.RobertsS.M., and StorerR. (1991) The potential for using carbocyclic nucleosides for the treatment of AIDS. Part 1. Preparation of some analogues for azidothymidine (AZT). J Chem Soc Perkin Trens1: 1127–1134.
13.
HuangJ.-T.ChenL.-C.WangL.KimM.-H.WarshawJ.A.ArmstrongD.ZhuQ.-Y.ChouT.-C.WatanabeK.A.Matulic-AdamicJ.SuT.-L.FoxJ.J.PolskyB.BaronP.A.GoldJ.W.M.HardyW.D., and ZuckermanÈ. (1991) Fluorinated sugar analogues of potential anti-HIV-1 nucleosides. J Med Chem34: 1640–1646.
14.
HurynD.M., and OkabeM. (1992) AIDS-driven nucleoside chemistry. Chem Rev92: 1745–1768.
15.
JohnstonM.I., and HothD.F. (1993) Present status and future prospects for HIV therapies. Science260: 1286–1293.
16.
KowollikG.EtzoldG.von Janta-LipinskiM.GaertnerK., and LangenP. (1973) Nucleoside von Fluorzuckern. XII. Ein neuer Zugang zu 1-(2,3-didesoxy-3-fluor-β-D-ribofuranosyl)-pyrimidinen. J Prakt Chem315: 895–900.
17.
KumarR.WangL.WiebeL.I., and KnausE.E. (1994) Synthesis and antiviral (HIV-1, HBV) activities of 5-halo-6-methoxy (or azido)-5, 6-dihydro-3′-fluoro-3′-deoxythymidine diastereomers. Potential prodrugs to 3′-fluoro-3′-deoxythymidine. J Med Chem37: 3554–3560.
18.
LeeY.-H.KimH.K.YounI.K., and ChaeY.B. (1991) Synthesis of novel 1′-nitrogen replaced carbocyclic thymidine analogs as potential anti-AIDS agents. Bioorg Med Chem Lett1: 287–290.
19.
LinT.-S.ZhuJ.-L.DutschmanG.E.ChengY.-C., and PrusoffW.H. (1993) Syntheses and biological evaluations of 3′-deoxy-3′-C-branched-chain-substituted nucleosides. J Med Chem36: 353–362.
20.
MotawiaM.S.JørgensenP.T.LarnkjærA.PedersenE.B., and NielsenC. (1993) Synthesis of 5-dialkylaminomethyl-3′-azido and 3′-fluoro-2′,3′-dideoxyuridines for evaluation as anti-HIV agents. Monatsh Chem124: 55–64.
21.
SchmidtL.PedersenE.B., and NielsenC. (1994) 5′-Azido and 5′-fluoro α-nucleosides as analogues of AZT and FLT. Acta Chem Scand48: 215–221.
22.
van AerschotA.HerdewijnP.BalzariniJ.PauwelsR., and De ClercqE. (1989) 3′-Fluoro-2′,3′-dideoxy-5-chlorouridine: most selective anti-HIV-1 agent among a series of new 2′-and 3′-fluorinated 2′,3′-dideoxynucleoside analogues. J Med Chem32: 1743–1749.
